Neuroglee gets $2.3 million to develop digital therapeutics for neurodegenerative diseases
Neuroglee gets $2.3 million to develop digital therapeutics for neurodegenerative diseases
There are now about 50 million people with dementia globally, a number the World Health Organization expects to triple by 2050. Alzheimer’s is the leading cause of dementia and caregivers are often overwhelmed, without enough support. Neuroglee, a Singapore-b…
